INCIPOD-CV DRY SYP

INCIPOD-CV DRY SYP

Composition

Each 5ml Contains: - Cefpodoxime Proxetil 50mg + Potassium Clavulanate 31.25mg

Indication

InciPod CV Dry Syrup, containing Cefpodoxime Proxetil 50mg and Potassium Clavulanate 31.25mg Dry Syrup, are a potent treatment for respiratory tract infections. This combination leverages the antibacterial efficacy of Cefpodoxime Proxetil and the beta-lactamase inhibiting properties of Clavulanic Acid. Cefpodoxime Proxetil disrupts bacterial cell wall synthesis, crucial for bacterial survival, while Clavulanic Acid prevents the breakdown of the antibiotic by beta-lactamase enzymes, thereby enhancing its effectiveness against a broad spectrum of bacteria.

InciPod CV Dry Syrup is specially formulated to effectively treat infections such as bronchitis, pneumonia, and sinusitis. By inhibiting bacterial resistance mechanisms, it supports faster recovery and helps prevent complications related to respiratory infections. This formulation is developed by trusted pharmaceutical companies dedicated to providing safe and effective healthcare solutions.

The synergy between Cefpodoxime Proxetil and Potassium Clavulanate in InciPod CV Dry Syrup underscores their role as a reliable treatment option, addressing both bacterial diversity and resistance challenges in respiratory tract infections. This combination not only targets pathogens effectively but also helps mitigate the risk of antibiotic resistance, making it a preferred choice among healthcare providers for managing respiratory infections comprehensively.

Contraindication

Nausea, Diarrhea, Headache, Rash, Abdominal pain, vaginal infection, fungal infection of vagina

Storage

Cool & Dry Place

Dosage

As directed by a Medical Practitioner or Physician.

Inquire Now